Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-24-064 from the NIH Guide for Grants and Contracts. This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to target via traditional drug discovery methodologies.